Cervical cancer (CC) is a neoplasm with great potential for prevention, but it is still a public health problem in most developing
countries. There are no significant differences between the use of high dose rate (HDR-BT) and low dose rate (LDR-BT) brachytherapy
when considering overall, disease specific and recurrence free survivals. Cervical dilatation is mandatory for the insertion of intrauterine
tandems in any of the techniques cited above. Pain and discomfort may eventually be limiting factors of the outpatient
procedure and may lead to unsatisfactory results in terms of adequate position of the applicator set. We reviewed the current
sedation and anesthetic options for comfort and safety procedures when performing HDR-BT.